Histologic precursors of gastrointestinal tract malignancy

Gastroenterology Clinics of North America

Volumn 31, Issue 2, 2002, Pages 395-419

  Haber, Marian M ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOMA; ADENOMATOUS POLYP; ATROPHIC GASTRITIS; CONDYLOMA ACUMINATUM; CYTOARCHITECTURE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DYSPLASIA; ENTERITIS; FLOW CYTOMETRY; GASTROINTESTINAL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; INTESTINE MUCOSA; MULTIPLE ENDOCRINE NEOPLASIA; POLYP; PRECANCER; PROTEIN EXPRESSION; REVIEW; ZOLLINGER ELLISON SYNDROME; CELL TRANSFORMATION; EPITHELIUM; ESOPHAGUS; ESOPHAGUS TUMOR; GASTROINTESTINAL TUMOR; INTESTINE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; STOMACH;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GASTROINTESTINAL NEOPLASMS; HUMAN; INTESTINES; PRECANCEROUS CONDITIONS; STOMACH; HUMANS;

EID: 0035992171     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(02)00007-9     Document Type: Review

References (95)

1. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications
2. Gastric dysplasia-like epithelial atypia associated with chemoradiotherapy for esophageal cancer: A clinicopathologic and immunohistochemical study of 15 cases
3. Observer variation in the diagnosis of dysplasia in Barrett's esophagus
4. Squamous dysplasia and early esophageal cancer in the Linxian region of China: Distinctive endoscopic lesions
5. Diffuse pagetoid squamous cell carcinoma in situ of the esophagus. A case report
6. Tumors of the esophagus and stomach
7. Esophageal squamous histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China
8. Histologic precursors of squamous esophageal cancer
9. Proliferative abnormalities of the oesophageal epithelium of Chinese populations at high and low risk for oesophageal cancer
10. Serial histologic investigation of squamous epithelial dysplasia associated with carcinoma of the esophagus
11. Superficial spreading carcinoma of the esophagus
12. Barrett's esophagus: A prevalent occult complication of gastroesophageal reflux disease
13. Distribution of dysplasia and early invasive carcinoma in Barrett's esophagus
14. Polypoid dysplasia in Barrett's esophagus: A clinicopathologic immunohistochemical, and molecular study of five cases
15. Esophageal submucosal gland duct adenoma
16. Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett's esophagus)
17. When is the columnar-lined esophagus premalignant?
18. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus
19. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction
20. Barrett's esophagus
21. Barrett's esophagus, dysplasia, and adenocarcinoma
22. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation
23. Prognostic value of DNA ploidy and c-erB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus
24. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma
25. Flow-cytometric and histological progression to malignancy in Barrett's eosphagus: Prospective endocsopic surveillance of a cohort
26. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation
27. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus
28. Transforming growth factor-alpha, epidermal growth factor receptor, and MIB-1 expression in Barrett's-associated neoplasia: Correlation with prognosis
29. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus
30. Immunohistochemical detection of p53 protein could improve the management of some patients with Barrett esophagus and mild histologic alterations
31. p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: Immunohistochemical marker predictive of progression
32. Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma
33. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma
34. Barrett's esophagus: Development of dysplasia and adenocarcinoma
35. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus
36. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus
37. Dysplasia in Barrett's esophagus: A clinicopathologic study of six patients
38. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus
39. Long-term follow-up of Barrett's high-grade dysplasia
40. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma
41. Human gastric carcinogenesis: Multistep and mutifocal process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention
42. Epithelial polyps of the stomach
43. Clinical relevance of gastric and duodenal polyps
44. Carcinoma in gastric hyperplastic polyps: A phenotypic study
45. Dysplasia and dysregulation of proliferation in foveolar and surface epithelial of fundic gland polyps from patients with familial adenomatous polyposis
46. Dysplasia of nonmetaplastic gastric mucosa: A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma
47. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas
48. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up
49. Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: A comparative analysis of biopsy and gastrectomy material
50. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer
51. Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa
52. Prospects for intervention in gastric carcinogenesis: Reversibility of gastric atrophy and intestinal metaplasia
53. Is the multiple endocrine neoplasia type I gene a suppressor for fundic argyrophil tumors in Zollinger-Ellison syndrome
54. Histopathological classification of nonantral gastric endocrine growths in man
55. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study
56. Adenomas of the small intestine: A clinicopathologic review of 51 cases and a study of their relationship to carcinoma
57. Villous tumors of the duodenum
58. Misplacement of dysplastic epithelium in Peutz-Jeghers polyps: The ultimate diagnostic pitfall?
59. Very high risk of cancer in familial Peutz-Jehgers syndrome
60. Premalignant and early malignant lesions in the gastrointestinal tract: Definitions, terminology, and problems
61. Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals
62. Predictors of presence, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand
63. Gender differences in colorectal polyps and tumors
64. The National Polyp Study: Design, methods, and characteristics of patients with newly diagnosed polyps
65. Studies on the morphogenesis of adenomatous polyps in the human colon
66. Pathology of the malignant colorectal polyp
67. Carcinomas and other epithelial and neuroendocrine tumors of the large intestine
68. Precursors of colorectal carcinoma: Biopsy and biologic markers
69. Histopathology of the larger colonic polyp
70. Pathology of colorectal adenomas: A colonoscopic survey
71. Flat adenomas of the colon
72. Flat adenoma as a precursor of colorectal carcinoma in hereditary nonpolyposis colorectal carcinoma
73. Mixed hyperplastic adenomatous polyps/serrated adenoma: A distinct form of colorectal neoplasia
74. Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps
75. Juvenile polyposis - A precancerous condition
76. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation
77. Histology of aberrant crypt foci in the human colon
78. Aberrant crypt foci in the human colon: Frequency and histologic patterns in patients with colorectal cancer or diverticular disease
79. Serrated route to colorectal cancer: Back street or super highway?
80. Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps
81. Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis
82. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy
83. Cancer surveillance in ulcerative colitis
84. Longterm outcome of UC patients with and without low grade dysplasia (LGD)
85. Long-term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen
86. Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years
87. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis
88. Cancer risk and life expectancy of children with ulcerative colitis
89. Cancer in universal and left-sided ulcerative colitis: Factors determining risk
90. Inflammatory bowel disease and colon cancer
91. Screening and surveillance colonoscopy in chronic Crohn's colitis
92. The relationship of human papillomaviruses to anorectal neoplasia
93. Cancer of the anal region
94. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis
95. Association between anorectal dysplasia, human papillomavirus and human immunodeficiency virus infection in homosexual men